Filing Flows › Comparisons › RNXT vs VTAK
RenovoRx vs Flyte Aviation: RNXT and VTAK compared
RenovoRx is the larger company: $1.1M of revenue in its latest quarter (Q3 2026) against $1.0M for Flyte Aviation (Q2 2026). Flyte Aviation is growing faster (+381% against +301% a year earlier). RenovoRx is more profitable, with an operating margin of -303.6% against -388.1%.
Where the money goes: RNXT and VTAK
RenovoRx (RNXT) · Q3 2026
RenovoRx, Q3 2026: revenue $1.1M (+301% year over year), operating margin -303.6%, net loss $3.6M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
Flyte Aviation (VTAK) · Q2 2026
Flyte Aviation, Q2 2026: revenue $1.0M (+381% year over year), operating margin -388.1%, net loss $3.3M, operating cash flow −$2.9M. The chart follows the revenue to costs, profit and cash.
| RenovoRx (RNXT) | Flyte Aviation (VTAK) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $1.1M | $1.0M |
| Revenue growth, Y/Y | +301% | +381% |
| Operating margin | -303.6% | -388.1% |
| Net earnings | −$3.6M | −$3.3M |
| Net margin | -342.1% | -324.4% |
| Operating cash flow | −$2.5M | −$2.9M |
Where the revenue comes from
Flyte Aviation
- Service: $749K (74%)
- Product: $270K (26%)
Questions
Which is bigger, RenovoRx or Flyte Aviation?
RenovoRx is the larger company: $1.1M of revenue in its latest quarter (Q3 2026) against $1.0M for Flyte Aviation (Q2 2026).
Is RenovoRx or Flyte Aviation growing faster?
Flyte Aviation is growing faster (+381% against +301% a year earlier).
Which is more profitable, RenovoRx or Flyte Aviation?
RenovoRx is more profitable, with an operating margin of -303.6% against -388.1%.
More: RenovoRx earnings · how RenovoRx makes money · Flyte Aviation earnings · how Flyte Aviation makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.